Pharm Final Deck

Cards (75)

  • Cyclophosphamide indication?

    Part of multi-agent protocols in the treatment of canine and feline lymphomas and canine malignant mammary gland tumors.
  • Cyclophosphamide adverse effect?
    myelosupression
    GI toxicity
    Alopecia
    Sterile hemorrhagic cystitis infrequently - if cystitis occurs the stop drug
  • Chlorambucil indictions?
    slower growing neoplasia such as chronic lymphocytic leukemia and also lymphoma and mast cell tumor
  • Chlorambucil Adverse effects?
    myelosuppression neutropenia
  • Melphalan indication?

    treat multiple myeloma in dogs and cats.
    used a rescue therapy for relapsed lymphoma in dogs.
  • Melphalan adverse effects?
    myelosuppression - delayed
    thrombocytopenia cats > dogs
  • lomustine indications?

    BBB
    treat tumors in brain and meninges.
    brain tumor, histocystic sarcoma, meat cell tumors, epitheliotropic and relapsed or refractory lymphomas.
    adverse effects:
    severe cumulative depressive effect on bone marrow.
    hepatotoxicity with chronic use
  • Class 1A : sodium channel blocker
    Quinidine ?
    manage atrial fibrillation in horse \prolongs refractory period of atrial muscles.
    Adverse : hypotension, prolonged QRS complex, arrhythmias, decrease contractibility.
    urticarial wheels, colic like symptoms, inflammation of nasal mucosa, respiratory difficulty and laminitis
  • Class 1 A : sodium channel blocker
    Procainamide ?
    treat ventricular and super ventricular tachycardia arrhythmias. not first choice because of adverse side effects.
    adverse: Pro-arrhythmic, GI signs, widen QRS and QT intervals, hypotension
  • Class 1B: sodium channel blocker
    Lidocaine?
    acutely converting ventricular arrhythmia to sinus rhythm.
    rapid effects. Do not administer orally.
    adverse: neuro =cats
    Do not use in cats
  • Class 1B: sodium blocker
    Mexiletine?
    orally administration
    chronic management of ventricular arrhythmia
    adverse : safe drug. loss appetite or vomiting, nausea, anorexia, depression , bradycardia
  • Class 2: decrease ventricular response
    Atenolol ?
    atrial fibrillation
    supraventricular tachycardias
    adverse: ventricular and supraventricular tachyarrhythmias
  • Class 2 :
    Esmolol ?
    acute termination of rapid supraventricular tachycardias
    adverse : ventricular and supraventricular tachyarrhythmias (acute management )
  • Class 2 :
    Metoprolol?
    atrial fibrillation, supraventricular tachycardias
    adverse: ventricular and supraventricular arrhythmias - chronic management
  • Class 2:
    Propanolol?
    supraventricular tachycardias
    adverse:atrial fibrillation and ventricular tachyarrhythmias
  • Sotalol? As B antagonist
    Supraventricular tachycardias and ventricular tachycardias
    adverse: ventricular tachyarrhythmias
  • Class 3 : K blocker
    Aminodarone?
    orally
    treat very difficult atrial fibrillation and ventricular tachyarrhythmias in dogs.
    atrial fibrillation in horses
    adverse: dose dependent, anorexia, vomiting, severe neutropenia, thrombocytopenia and hepatotoxicity.
    dobermans more prone.
  • Class 3 : k blocker
    Sotatol?
    weak blocker
    very effective and safe ventricular tachyarrhythmic
    add to mexiletine
    limited adverse effects
  • Class 4 : calcium blocker
    Amlodipine?
    manage systemic hypertension
    treat heart failure
    preferred drug for systemic hypertension in cats
    adverse: new inotropic effects, reduce cardiac output, and hypotension, sinus bradycardia and heart block.
  • Class 4 : calcium blocker
    Diltiazem?

    supraventricular tachycardia
  • Digoxin?
    anti-arrhythmic
    congestive heart failure
    atrial fibrilllation
    adverse: dose dependent based on body weight
    mild GI upset
    neurological signs
    Death, inappetence, depression, loose stool, vomiting with diarrhea
  • Pimobendan?
    increases inotropy
    balance vasodilation
    positive Iusitropic effects - increased rate of myocardial relaxation
    adverse: well tolerated and safe
    do not use din patients with outflow obstruction
  • Benazepril and Enalapril?
    chronic management of heart failure
    management of systemic hypertension. clinical and subclinical cardiac diseases and proteins renal disease. chronic kidney disease.
    adverse: hypotension
  • Prazosin - vasodilator ?
    renal hypertension
    vesicourethral reflex dyssynergia in dogs ( urinary incontience)
  • Hydralazine Hydrochloride?

    oral
    management of congestive heart failure secondary to myxomatous mitral valve disease
    adverse: tachycardia, hypotension, monitor heart rate after given drug
  • Amlodipine - vasodilators?
    manage systemic hypertension
    treat heart failure
    adverse: negative inotropic effects
    reduce CO and hypertension
    sinus bradycardia
    heart block
  • sodium nitroprusside ?
    supplemental to loop diuretics.
    adverse : stop drug after 24hours bc of tolerance
  • Sildenafil ?
    naturally occurring pulmonary hypertension in dogs with concurrent MMVD
  • Apomorphine?
    emetic drug
    effective in dogs, not for cats.
    vomiting in 5-10 min
    do not work on sedated and motionless animals
    do not give IM
  • Ropinrole?
    emetic drug
    effective in dogs
    administered as eye drops
  • Xylazine ?
    emetic drug
    effective in cats
    adverse: profound sedation and hypotension so please monitor patient
  • dexmedatomidine?
    emetic drug
  • hydrogen peroxide?
    small doses until animal vomits
    administer cautiously in cats because foam causes aspiration pneumonia
  • Chlorpromazine and acepromazine?
    broad spectrum antiemetic
    adverse: sedation, altered involuntary movements, vasodilation
  • Atropine?
    Not first drug to use
    antiemetic
    cases of vestibular stimulation (motion sickness)
    adverse: xerostomia (dry mouth)
    decrease stomach emptying, ileus, urine retention, constipation
  • Diphenhydramine and Dimenhydrinate?
    safe drug lead to sedation
  • Metoclopramide?
    antiemetic drug
    vomiting caused by GI disease
    adverse: CNS effects = excitement and behavior changes observed, + GI motility leading to abdominal discomfort
    Do not use when you have GI obstruction
  • ondansetron and dolasetron?
    vomiting associated with Cancer chemotherapy, gastroenteritis, pancreatitis, inflammatory bowel disease
    adverse : constipation, sleepiness, head shaking, abnormal heart rhythms, low BP, fainting/collapse or severe lethargy.
    GIVE SQ
  • Maropitant?

    broad spectrum antiemetic - dogs and cats
    doesn’t help nausea
    adverse: analgesia and decrease coughing
  • Mirtazapine?
    antiemetic and appetite stimulant. (Anti-nausea)
    cats with chronic kidney disease
    not for dogs !